Agomelatine Attenuates Isoflurane-Induced Inflammation and Damage in Brain Endothelial Cells

References

• BjurKA, PayneET, NemergutME, et alHu D, and Flick RP. Anesthetic-related neurotoxicity andneuroimaging in children: a call for conversation. J Child Neurol. 2017;32(6):594–602. doi:10.1177/088307381769169628424007
   PubMed Web of Science ®Google Scholar
• KangE, WenZ, SongH, ChristianKM, MingGL. Adult neurogenesis and psychiatric disorders. Cold Spring Harb Perspect Biol. 2016;8.
   Web of Science ®Google Scholar
• Jevtovic-TodorovicV, HartmanRE, IzumiY, et al. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci. 2003;23(3):876–882. doi:10.1523/JNEUROSCI.23-03-00876.200312574416
   PubMed Web of Science ®Google Scholar
• WuJ, HaoS, SunXR, et al. (SS-31) ameliorates isoflurane-induced long-term impairments of mitochondrial morphogenesis and cognition in developing rats. Front Cell Neurosci. 2017;11:119.28487636
   PubMed Web of Science ®Google Scholar
• ZhuC, GaoJ, KarlssonN, et al. Isoflurane anesthesia induced persistent, progressive memory impairment, caused a loss of neural stem cells, and reduced neurogenesis in young, but not adult, rodents. J Cereb Blood Flow Metab. 2010;30(5):1017–1030. doi:10.1038/jcbfm.2009.27420068576
   PubMed Web of Science ®Google Scholar
• Jevtovic-TodorovicV. General anesthetics and neurotoxicity: how much do we know? Anesthesiol Clin. 2016;34(3):439–451. doi:10.1016/j.anclin.2016.04.00127521190
   PubMedGoogle Scholar
• ChengY, HeL, PrasadV, WangS, LevyRJ. Anesthesia-induced neuronal apoptosis in the developing retina: a window of opportunity. Anesth Analg. 2015;121(5):1325–1335. doi:10.1213/ANE.000000000000071426465931
   PubMed Web of Science ®Google Scholar
• FlickRP, KatusicSK, ColliganRC, et al. Cognitive and behavioral outcomes after early exposure to anesthesia and surgery. Pediatrics. 2011;128:e1053–e1061.21969289
   PubMed Web of Science ®Google Scholar
• StratmannG, LeeJ, SallJW, et al. Effect of general anesthesia in infancy on long-term recognition memory in humans and rats. Neuropsychopharmacology. 2014;39(10):2275–2287. doi:10.1038/npp.2014.13424910347
   PubMed Web of Science ®Google Scholar
• KangE, BergDA, FurmanskiO, et al. Neurogenesis and developmental anesthetic neurotoxicity. Neurotoxicol Teratol. 2017;60:33–39. doi:10.1016/j.ntt.2016.10.00127751818
   PubMed Web of Science ®Google Scholar
• DittmarMS, PetermichlW, LindnerR, et al. In vitro induction of endothelial apoptosis of the post-hypoxic blood-brain barrier by isoflurane but not by sevoflurane and midazolam. PLoS One. 2015;10(6):e0130408. doi:10.1371/journal.pone.013040826091107
   PubMed Web of Science ®Google Scholar
• DittmarMS, PetermichlW, SchlachetzkiF, GrafBM, GruberM. Isoflurane induces endothelial apoptosis of the post-hypoxic blood-brain barrier in a transdifferentiated human umbilical vein endothelial cell model. PLoS One. 2012;7:e38260. doi:10.1371/journal.pone.003826022723852
   PubMed Web of Science ®Google Scholar
• HuQ, MaQ, ZhanY, et al. Isoflurane enhanced hemorrhagic transformation by impairing antioxidant enzymes in hyperglycemic rats with middle cerebral artery occlusion. Stroke. 2011;42(6):1750–1756. doi:10.1161/STROKEAHA.110.60314221474807
   PubMed Web of Science ®Google Scholar
• PillaiDR, DittmarMS, BaldaranovD, et al. Cerebral ischemia-reperfusion injury in rats–a 3 T MRI study on biphasic blood-brain barrier opening and the dynamics of edema formation. J Cereb Blood Flow Metab. 2009;29:1846–1855. doi:10.1038/jcbfm.2009.10619654585
   PubMed Web of Science ®Google Scholar
• ThalSC, LuhC, SchaibleEV, et al. Volatile anesthetics influence blood-brain barrier integrity by modulation of tight junction protein expression in traumatic brain injury. PLoS One. 2012;7:e50752. doi:10.1371/journal.pone.005075223251381
   PubMed Web of Science ®Google Scholar
• LiuJ, JinX, LiuKJ, LiuW. Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage. J Neurosci. 2012;32(9):3044–3057. doi:10.1523/JNEUROSCI.6409-11.201222378877
   PubMed Web of Science ®Google Scholar
• TetraultS, CheverO, SikA, AmzicaF. Opening of the blood-brain barrier during isoflurane anaesthesia. Eur J Neurosci. 2008;28(7):1330–1341. doi:10.1111/j.1460-9568.2008.06443.x18973560
   PubMed Web of Science ®Google Scholar
• HeHJ, WangY, LeY, et al. Surgery upregulates high mobility group box-1 and disrupts the blood-brain barrier causing cognitive dysfunction in aged rats. CNS Neurosci Ther. 2012;18:994–1002.23078219
   PubMed Web of Science ®Google Scholar
• TerrandoN, ErikssonLI, RyuJK, et al. Resolving postoperative neuroinflammation and cognitive decline. Ann Neurol. 2011;70(6):986–995. doi:10.1002/ana.2266422190370
   PubMed Web of Science ®Google Scholar
• Guardiola-LemaitreB, De BodinatC, DelagrangeP, MillanMJ, MunozC, MocaerE. Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties. Br J Pharmacol. 2014;171:3604–3619.24724693
   PubMed Web of Science ®Google Scholar
• GumusluE, MutluO, SunnetciD, et al. The antidepressant agomelatine improves memory deterioration and upregulates CREB and BDNF gene expression levels in unpredictable chronic mild stress (UCMS)-exposed mice. Drug Target Insights. 2014;8:11–21. doi:10.4137/DTI.S1387024634580
   PubMedGoogle Scholar
• De BerardisD, FornaroM, SerroniN, et al. and Di Giannantonio M. Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression. Int J Mol Sci. 2015;16(1):1111–1130. doi:10.3390/ijms1601111125569089
   PubMed Web of Science ®Google Scholar
• ChumboatongW, ThummayotS, GovitrapongP, TocharusC, JittiwatJ, TocharusJ. Neuroprotection of agomelatine against cerebral ischemia/reperfusion injury through an antiapoptotic pathway in the rat. Neurochem Int. 2017;102:114–122.28012846
   PubMed Web of Science ®Google Scholar
• YaoK, ZhaoYF, ZuHB. Melatonin receptor stimulation by agomelatine prevents Abeta-induced tau phosphorylation and oxidative damage in PC12 cells. Drug Des Devel Ther. 2019;13:387–396.
   PubMed Web of Science ®Google Scholar
• ZhangBP, LiJB. Phoenixin-14 protects human brain vascular endothelial cells against oxygen-glucose deprivation/reoxygenation (OGD/R)-induced inflammation and permeability. Arch Biochem Biophys. 2020;682:108275.31962109
   PubMed Web of Science ®Google Scholar
• ChowBW, GuC. The molecular constituents of the blood-brain barrier. Trends Neurosci. 2015;38:598–608.26442694
   PubMed Web of Science ®Google Scholar
• AdamsRA, BauerJ, FlickMJ, et al. The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease. J Exp Med. 2007;204:571–582.17339406
   PubMed Web of Science ®Google Scholar
• ZhuH, LiuW, FangH. Inflammation caused by peripheral immune cells across into injured mouse blood-brain-barrier can worsen postoperative cognitive dysfunction induced by isoflurane. BMC Cell Biol. 2018;19:23.30268095
   PubMedGoogle Scholar
• ChenF, QianLH, DengB, LiuZM, ZhaoY, LeYY. Resveratrol protects vascular endothelial cells from high glucose-induced apoptosis through inhibition of NADPH oxidase activation-driven oxidative stress. CNS Neurosci Ther. 2013;19:675–681.23731528
   PubMed Web of Science ®Google Scholar
• ZhouHG, LiuL, ZhangY, et al. Glutathione prevents free fatty acids-induced oxidative stress and apoptosis in human brain vascular endothelial cells through Akt pathway. CNS Neurosci Ther. 2013;19:252–261.23521913
   PubMed Web of Science ®Google Scholar
• YanSF, FujitaT, LuJ, et al. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med. 2000;6:1355–1361.11100120
   PubMed Web of Science ®Google Scholar
• FujitaT, AsaiT, AndrassyM, et al. PKCbeta regulates ischemia/reperfusion injury in the lung. J Clin Invest. 2004;113:1615–1623.15173888
   PubMed Web of Science ®Google Scholar
• HuangC, ChangJS, XuY, LiQ, ZouYS, YanSF. Reduction of PKCbetaII activity in smooth muscle cells attenuates acute arterial injury. Atherosclerosis. 2010;212:123–130.20594553
   PubMed Web of Science ®Google Scholar
• KumarH, SharmaBM, SharmaB. Benefits of agomelatine in behavioral, neurochemical and blood-brain-barrier alterations in prenatal valproic acid-induced autism spectrum disorder. Neurochem Int. 2015;91:34–45.26498253
   PubMed Web of Science ®Google Scholar
• De BerardisD, FornaroM, OrsoliniL, et al. Effects of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in “real-world”, everyday clinical practice. CNS Spectr. 2017;22:342–347.27702411
   PubMed Web of Science ®Google Scholar
• FonsecaFA, IzarMC. High-sensitivity c-reactive protein and cardiovascular disease across countries and ethnicities. Clinics. 2016;71(4):235–242.27166776
   PubMed Web of Science ®Google Scholar
• LiuJ, CloughSJ, HutchinsonAJ, Adamah-BiassiEB, Popovska-GorevskiM, DubocovichML. MT1 and MT2 melatonin receptors: a therapeutic perspective. Annu Rev Pharmacol Toxicol. 2016;56:361–383.26514204
   PubMed Web of Science ®Google Scholar
• Pandi-PerumalSR, TrakhtI, SrinivasanV, et al. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways Prog. Neurobiol. 2008;85:335–353.
   Google Scholar
• JiaP, LiuC, WuN, JiaD, SunY. Agomelatine protects against myocardial ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Am J Transl Res. 2018;10(5):1310–1323.29887947
   PubMed Web of Science ®Google Scholar